Zdrowie i gospodarka · 04/10/2016

FDA Denies Exemption for Reagent Tablet Format Urinary Glucose Test System

The FDA has denied a petition to exempt method, metallic reduction, glucose (urinary, nonquantitative) devices in a reagent tablet format from premarket notification requirements, citing procedures established by the Food and Drug Administration Modernization Act of 1997.